首页> 外国专利> MARKER GROUP FOR MAKING DIAGNOSIS TO DISTINGUISH CORONARY ARTERIAL ATHEROSCLEROSIS FROM STABLE ANGINA PECTORIS

MARKER GROUP FOR MAKING DIAGNOSIS TO DISTINGUISH CORONARY ARTERIAL ATHEROSCLEROSIS FROM STABLE ANGINA PECTORIS

机译:马克集团进行诊断以区分稳定型心绞痛的冠状动脉粥样硬化

摘要

A marker group for making diagnosis to distinguish coronary arterial atherosclerosis from stable angina pectoris. The marker group comprises one or more of glutathione, β-hydroxybutyric acid, proline, fumaric acid, phenylalanine and lactic acid. When a single marker is used for making diagnosis to distinguish patients with the stable angina pectoris from patients with the coronary arterial atherosclerosis, the areas under curve (AUC) of a ROC curve are all 0.7 or larger, and the marker has a clinical diagnosis significance; when the marker is used for diagnosis in combination, with the increase of the combination number, the AUC is further increased and reaches 0.988 when 6 markers are combined, and the sensitivity and the specificity are 98.5% and 98.3% respectively under the optimum cutoff value. The metabolic marker group can be used to accurately making diagnosis to distinguish the coronary arterial atherosclerosis from the stable angina pectoris, and has high sensitivity and specificity.
机译:进行诊断以区分冠状动脉粥样硬化与稳定型心绞痛的标志物组。标记物基团包括谷胱甘肽,β-羟基丁酸,脯氨酸,富马酸,苯丙氨酸和乳酸中的一种或多种。当使用单一标记物进行诊断以区分稳定型心绞痛的患者和冠状动脉粥样硬化患者时,ROC曲线的曲线下面积(AUC)均为0.7或更大,该标记物具有临床诊断意义;组合使用时,随着组合数的增加,组合6种标志物时AUC进一步增加,达到0.988,在最佳临界值下灵敏度分别为98.5%和98.3%。 。代谢标记物组可用于准确做出诊断,以将冠状动脉粥样硬化与稳定的心绞痛区分开来,并且具有很高的敏感性和特异性。

著录项

  • 公开/公告号WO2017161595A1

    专利类型

  • 公开/公告日2017-09-28

    原文格式PDF

  • 申请/专利权人 QI LIANWEN;

    申请/专利号WO2016CN77606

  • 发明设计人 LI PING;ZHU WEI;CHEN YAN;FAN YONG;

    申请日2016-03-29

  • 分类号G01N30/02;

  • 国家 WO

  • 入库时间 2022-08-21 13:29:42

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号